Russia at a glance
- Population
- 143.5 million 2025
- Life expectancy at birth
- 73.4 years, 2024
- People aged 65 and over
- 17.8 % of people, 2025
- Health spending per person
- 1,003 US$ per person, 2023
- Doctors
- 5.11 per 1,000 people, 2022
Updated
Reviewed by Vidhi Upadhyay
Russia Glaucoma Surgery Devices Market Industry Trends and Forecast to 2034: Segmented by (Product, Procedure, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$18.8 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $14.7 Mn | — | — |
| 2025 (base) | $16.0 Mn | +$1.3 Mn | — |
| 2026 (forecast) | $17.5 Mn | +$1.4 Mn | +9% |
| 2027 (forecast) | $19.1 Mn | +$1.6 Mn | +18.8% |
| 2028 (forecast) | $20.8 Mn | +$1.7 Mn | +29.5% |
| 2029 (forecast) | $22.6 Mn | +$1.9 Mn | +41.2% |
| 2030 (forecast) | $24.7 Mn | +$2.0 Mn | +53.9% |
| 2031 (forecast) | $26.9 Mn | +$2.2 Mn | +67.7% |
| 2032 (forecast) | $29.3 Mn | +$2.4 Mn | +82.8% |
| 2033 (forecast) | $32.0 Mn | +$2.6 Mn | +99.3% |
| 2034 (forecast) | $34.8 Mn | +$2.9 Mn | +117.2% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $16.0 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $34.8 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 9.0% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product, procedure and end user (see all) |
| Key players | Glaukos, Alcon, Johnson & Johnson, Sight Sciences, Ellex (Lumibird) (see all) |
| Regulator in Russia | RoszdravnadzorSource: Roszdravnadzor. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Glaucoma surgery devices lower eye pressure using tiny stents, shunts and lasers, often during cataract surgery.
Key segments of the glaucoma Surgery Devices market include product (MIGS Devices, Glaucoma Drainage Devices and Laser Systems) and procedure (Standalone and Combined with Cataract Surgery).
An ageing population, more people with diabetes and long-term conditions, better treatments and wider access to specialist care are driving the glaucoma Surgery Devices market.
Longer-acting treatments, home-based care and screening in emerging markets give the glaucoma Surgery Devices market room to grow.
High costs of new treatments, specialist shortages, low awareness and limited reimbursement in some countries hold back the glaucoma Surgery Devices market.
The glaucoma Surgery Devices market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medical devices are registered by Roszdravnadzor, the federal health care regulator.[1] Compulsory medical insurance (OMS) pays for a guaranteed package of free care, through the Federal Compulsory Medical Insurance Fund.[2]
[1] Roszdravnadzor. Checked 14 Nov 2026.
[2] Federal Compulsory Medical Insurance Fund. Checked 14 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how glaucoma Surgery Devices products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Russia.
What doctors and scientists are doing in Glaucoma Surgery Devices right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.
Russia · 1 shared keyword
Russia · 1 shared keyword
Russia
Russia
Russia
Russia
Digital Health · Russia
Pharmaceuticals · Russia
Pharmaceuticals · Russia
OTC & Nutraceuticals · Russia
Pharmaceuticals · Russia
OTC & Nutraceuticals · Russia